Abstract
We report on the second and final part of a pre-registered forecasting study on COVID-19 cases and deaths in Germany and Poland. Fifteen independent research teams provided forecasts at lead times of one through four weeks from January through mid-April 2021. Compared to the first part (October–December 2020), the number of participating teams increased, and a number of teams started providing subnational-level forecasts. The addressed time period is characterized by rather stable non-pharmaceutical interventions in both countries, making short-term predictions more straightforward than in the first part of our study. In both countries, case counts declined initially, before rebounding due to the rise of the B.1.1.7 variant. Deaths declined through most of the study period in Germany while in Poland they increased after a prolonged plateau. Many, though not all, models outperformed a simple baseline model up to four weeks ahead, with ensemble methods showing very good relative performance. Major trend changes in reported cases, however, remained challenging to predict.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
J. Bracher, M. Schienle and T. Gneiting acknowledge support from the Helmholtz Foundation via the SIMCARD Information and Data Science Pilot Project. T. Gneiting and D. Wolffram are grateful for support by the Klaus Tschira Foundation. D. Wolffram's contribution was moreover supported by the Helmholtz Association under the joint research school HIDSS4Health - Helmholtz Information and Data Science School for Health. N.I. Bosse was supported by the Health Protection Research Unit (grant code NIHR200908). S. Funk and S. Abbott were supperted by the Wellcome Trust (210758/Z/18/Z). The itwm-dSEIR forecasting team (J. Fiedler, N. Leith\"auser, J. Mohring) was supported by the Ministry of Health and Science of Rhineland Palatinate and the Fraunhofer Anti-Corona Program. S. Bhatia acknowledges funding from the Wellcome Trust (219415). Work on the ICM UW epidemiological model (J.M Nowosielski, M. Radwan, F. Rakowski) was supported by the Polish Minister of Science and Higher Education grant 51/WFSN/2020 given to the University of Warsaw. Development of the IMISE-SECIR model (Y. Kheifetz, H. Kirsten, S. Scholz) was funded in the framework of the project SaxoCOV (Saxonian COVID-19 Research Consortium). SaxoCOV was co-financed with tax funds on the basis of the budget passed by the Saxon state parliament. Model presentation was funded by the NFDI4Health Task Force COVID-19 (www.nfdi4health.de/task-force-covid-19-2) within DFG project LO-342/17-1.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study contains publicly available surveillance data on COVID-19 (from Robert Koch Institute, the Polish Ministry of Health and Johns Hopkins CSSE). These data used have been deposited at https://github.com/KITmetricslab/covid19-forecast-hub-de
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available at https://github.com/KITmetricslab/covid19-forecast-hub-de
